Can Fite Biofarma (Can Fite Biofarma) Net Margin % : -1,065.81% (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Can Fite Biofarma Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Can Fite Biofarma's Net Income for the three months ended in Dec. 2023 was $-1.65 Mil. Can Fite Biofarma's Revenue for the three months ended in Dec. 2023 was $0.16 Mil. Therefore, Can Fite Biofarma's net margin for the quarter that ended in Dec. 2023 was -1,065.81%.

The historical rank and industry rank for Can Fite Biofarma's Net Margin % or its related term are showing as below:

CANF' s Net Margin % Range Over the Past 10 Years
Min: -5006.4 Med: -1256.14 Max: -172.02
Current: -1027.27

CANF's Net Margin % is ranked worse than
73.22% of 1027 companies
in the Biotechnology industry
Industry Median: -162.84 vs CANF: -1027.27

Can Fite Biofarma Net Margin % Historical Data

The historical data trend for Can Fite Biofarma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Can Fite Biofarma Net Margin % Chart

Can Fite Biofarma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-621.31

-1,892.92

-1,478.90

-1,255.93

-1,027.46

Can Fite Biofarma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %	Get a 7-Day Free Trial															-1,532.49	-1,301.02	-852.04	-898.98	-1,065.81

Competitive Comparison of Can Fite Biofarma's Net Margin %

For the Biotechnology subindustry, Can Fite Biofarma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Can Fite Biofarma's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Can Fite Biofarma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Can Fite Biofarma's Net Margin % falls into.

Can Fite Biofarma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Can Fite Biofarma's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-7.634	/	0.743
	=	-1,027.46 %

Can Fite Biofarma's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.652	/	0.155
	=	-1,065.81 %

Can Fite Biofarma (AMEX:CANF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Can Fite Biofarma Net Margin % Related Terms

Thank you for viewing the detailed overview of Can Fite Biofarma's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Can Fite Biofarma (Can Fite Biofarma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Can Fite Biofarma Ltd (AMEX:CANF) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

CANF:Israel

Address

10 Bareket Street, Kiryat Matalon, P.O. Box 7537, Petah-Tikva, ISR, 4951778

Website

http://www.canfite.com

Can Fite Biofarma Ltd is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. The company's lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).